Position in TMO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$235,639
-$14,549 QoQ
Shares Held
470
-7.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#2,184
of 2,606 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 19%
Shared 0%
None 81%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Second Line Capital, LLC holds $235,639 across 1 Diagnostics & Research name. TMO ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
470 | $235,639 |
All Filings in TMO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $235,639 | 470 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $250,188 | 509 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $227,723 | 393 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||